Company Presentation

FoRx Therapeutics AG

Category:Emerging Biotech Company
Date:April 24, 2023
Speaker:Tarig Bashir, CEO

Company profile

FoRx Therapeutics focuses on the discovery and development of small molecule inhibitors against key proteins involved in the response to oncogene-induced DNA replication stress, which constitutes an innovative approach to identifying novel, targeted anti-cancer drugs. The company has currently 15 employees and is backed by a syndicate of investors that include EQT Life Sciences, Novartis Venture Fund, Pfizer Ventures, Omega Funds and M Ventures.

Follow us